These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 10456450
1. Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group. Di Carlo V, Agnelli G, Prandoni P, Coccheri S, Gensini GF, Gianese F, Mannucci PM. Thromb Haemost; 1999 Jul; 82(1):30-4. PubMed ID: 10456450 [Abstract] [Full Text] [Related]
2. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV, Howes J, Sharma V, Kadziola Z. Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [Abstract] [Full Text] [Related]
3. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Agnelli G, Bergqvist D, Cohen AT, Gallus AS, Gent M, PEGASUS investigators. Br J Surg; 2005 Oct; 92(10):1212-20. PubMed ID: 16175516 [Abstract] [Full Text] [Related]
9. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P, Behounek J, Skoták M, Nevsímal L. Acta Chir Orthop Traumatol Cech; 2004 Oct; 71(4):237-44. PubMed ID: 15456102 [Abstract] [Full Text] [Related]
11. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery. Eriksson BI, Arfwidsson AC, Frison L, Eriksson UG, Bylock A, Kälebo P, Fager G, Gustafsson D. Thromb Haemost; 2002 Feb; 87(2):231-7. PubMed ID: 11858482 [Abstract] [Full Text] [Related]
15. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery. Colwell C, Mouret P. Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914 [Abstract] [Full Text] [Related]
16. Subcutaneous heparin for prophylaxis of venous thromboembolism in deep brain stimulation surgery: evidence from a decision analysis. Bauman JA, Church E, Halpern CH, Danish SF, Zaghloul KA, Jaggi JL, Stein SC, Baltuch GH. Neurosurgery; 2009 Aug; 65(2):276-80; discussion 280. PubMed ID: 19625905 [Abstract] [Full Text] [Related]
19. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery. Abad JI, Gómez-Outes A, Martínez-González J, Rocha E, Bemiparin 6 Hours After Surgery Study Group. Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172 [Abstract] [Full Text] [Related]
20. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Charbonnier BA, Fiessinger JN, Banga JD, Wenzel E, d'Azemar P, Sagnard L. Thromb Haemost; 1998 May; 79(5):897-901. PubMed ID: 9609216 [Abstract] [Full Text] [Related] Page: [Next] [New Search]